XML 17 R7.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended 12 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Cash flows from operating activities:      
Net loss $ (6,851) $ (38,721)  
Adjustments to reconcile net loss to cash used in operating activities:      
Amortization and depreciation 514 2,093  
Amortization of right-of-use asset 125 524  
Other non-cash losses (947) 18  
Provision for credit losses 7 154  
Loss on the sale of machinery and equipment 65 75  
Debt related charges included in interest expense 1,674 1,100  
Equity-based employee compensation expense 237 2,661  
Gain on change of contingent consideration   (195)  
Change in fair value of warrant liabilities (324) 723  
Change in fair value of derivative liability (459)    
Increase in inventory reserves 431    
Changes in operating assets and liabilities, net of acquisition:      
Accounts receivable (784) (3,322)  
Inventories 1,251 (4,285)  
Prepaid expenses and other assets (548) (2,178)  
Accounts payable 24 2,257  
Accrued expenses (437) 2,066  
Accrued payroll (583) (774)  
Accrued excise taxes and fees 276 1,280  
Other liabilities (641) (808)  
Net cash used in operating activities (6,970) (37,332)  
Cash flows from investing activities:      
Acquisition of patents, trademarks, and licenses   (398)  
Acquisition of property, plant and equipment (71) (2,759)  
Proceeds from the sale of property, plant and equipment 22 251  
Acquisition, net of cash acquired   90  
Property, plant and equipment insurance proceeds   3,500  
Sales and maturities of short-term investment securities   21,714  
Purchase of short-term investment securities   (3,475)  
Net cash (used in) provided by investing activities (49) 18,923  
Cash flows from financing activities:      
Payments on notes payable (924) (3,954)  
Proceeds from issuance of notes payable 1,256 2,218  
Payments of long-term debt (249)    
Proceeds from issuance of long-term debt   16,849  
Payment of debt issuance costs   (801)  
Proceeds from issuance of detachable warrants   6,016  
Net proceeds from warrant exercise 2,245    
Taxes paid related to net share settlement of RSUs (1) (420)  
Net cash provided by financing activities 6,240 27,322  
Net (decrease) increase in cash, cash equivalents and restricted cash (779) 8,913  
Cash, cash equivalents and restricted cash at beginning of period 2,058 3,020 $ 3,020
Cash, cash equivalents and restricted cash at end of period 1,279 11,933 2,058
Reconciliation of cash and cash equivalents and restricted cash      
Cash and cash equivalents at beginning of period 2,058 3,020 3,020
Cash, cash equivalents and restricted cash at beginning of period 2,058 3,020 3,020
Cash and cash equivalents at end of period 1,279 4,433 2,058
Restricted cash at end of period   7,500  
Cash, cash equivalents and restricted cash at end of period 1,279 11,933 $ 2,058
Non-cash transactions:      
Capital expenditures incurred but not yet paid 25 64  
Right-of-use assets and corresponding operating lease obligations   4,803  
Deemed dividends 4,034 367  
Stock issued in connection with settled indebtedness 1,192    
Non-cash consideration RXP acquisition   1,926  
Non-cash licensing arrangement   3,500  
Payment for extinguishment of Subordinated Note 3,864    
Payment of GVB Promissory Note 1,500    
Payment of debt issuance costs 275    
Equity conversion of Senior Secured Credit Facility 2,481    
ATM      
Cash flows from financing activities:      
Proceeds from issuance of common stock   2,741  
Payment of common stock issuance costs   (178)  
Registered Direct Offering      
Cash flows from financing activities:      
Proceeds from issuance of common stock 4,237 5,273  
Payment of common stock issuance costs $ (324) $ (422)